The only GLP-1 drug licensed purely for weight loss in the UK is Wegovy, while the others are approved just to control diabetics' blood sugar levels and not for weight loss.
Patients with type 2 diabetes are being left waiting months for vital drugs as the jabs they need are snapped up privately by those hoping to lose weight. There is such demand for the GLP-1 injections that it has created a global shortage prompting a UK ban on the medication - including the much talked about Ozempic - being prescribed to treat obesity.
'Illegally profiting' from people's health As head of care at Diabetes UK, Douglas Twenefour has significant concerns about exactly what people are getting hold of. 'These medications come with side effects so it's important that people get it from the right sources,' he said. 'You don't know the doses with which these medications are coming.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wegovy Is Good for More Than Just Weight LossIt's the first weight-loss drug to carry an indication for heart benefits.
Read more »
Ozempic maker 'very optimistic' after revealing new weight loss pill twice as effective as existing jabsThe maker of the weight loss drugs Ozepmic and WeGovy has revealed a new pill for weight loss that’s twice as effective as its existing jabs.
Read more »
New weight loss pill more effective than Ozempic: Novo NordiskAn experimental new weight loss pill from Danish pharmaceutical giant Novo Nordisk could be twice as effective as its blockbuster Ozempic and Wegovy jabs, early results from a small trial have suggested, sending the firm's shares soaring.
Read more »
With regular exercise, medical weight loss treatment does not have to be permanentFor nearly a year, we have been debating weight loss drugs like Wegovy, Zepbound, Saxenda and similar products and what happens when people stop taking them. Are they able to maintain weight loss? A new Danish study sheds light on the matter.
Read more »
Data provide new perspective for understanding the antidepressant-like effects of a diabetes drugResearch in animals has shown that the diabetes drug dulaglutide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist may reduce symptoms of depression. A new study published in Brain and Behavior reveals the mechanisms that are likely involved.
Read more »
Should ketchup be stored in the fridge or cupboard? We answer the questionIt's not a simple question to answer but we weigh up the arguments
Read more »